MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer
Open Access
- 20 February 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 120 (6), 621-632
- https://doi.org/10.1038/s41416-019-0395-8
Abstract
Background MicroRNAs are potent post-transcriptional regulators involved in all hallmarks of cancer. Mir-196a is transcribed from two loci and has been implicated in a wide range of developmental and pathogenic processes, with targets including Hox, Fox, Cdk inhibitors and annexins. Genetic variants and altered expression of MIR196A are associated with risk and progression of multiple cancers including breast cancer, however little is known about the regulation of the genes encoding this miRNA, nor the impact of variants therein. Methods Genomic data and chromatin interaction analysis were used to discover functional promoter and enhancer elements for MIR196A. Expression data were used to associate MIR196A with mechanisms of resistance, breast cancer subtypes and prognosis. Results Here we demonstrate that MIR196A displays complex and dynamic expression patterns, in part controlled by long-range transcriptional regulation between promoter and enhancer elements bound by ERα. Expression of this miRNA is significantly increased in drug-resistant models of hormone-receptor positive disease. The expression of MIR196A also proves to be a robust prognostic factor for patients with advanced and post-menopausal ER+ disease. Conclusion This work sheds light on the normal and abnormal regulation of MIR196A and provides a novel stratification method for therapeutically resistant breast cancer.Keywords
Funding Information
- National Breast Cancer Foundation (2012002037)
- The University of Queensland
- Department of Health | National Health and Medical Research Council (APP1058421, 1106907)
- Tenovus Cancer Care Charity Breast Cancer Now Fellowship Cardiff University
- U.S. Department of Health & Human Services | National Institutes of Health (CA1130001)
This publication has 79 references indexed in Scilit:
- Multiplexed analysis of chromosome conformation at vastly improved sensitivityNature Methods, 2015
- DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancerNature Communications, 2015
- Microprocessor Activity Controls Differential miRNA Biogenesis In VivoCell Reports, 2014
- Building a Robust A-P AxisCurrent Genomics, 2012
- PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast CancerPLoS Genetics, 2011
- FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistanceOncogene, 2010
- Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 geneProceedings of the National Academy of Sciences of the United States of America, 2008
- Quantitative analysis of chromosome conformation capture assays (3C-qPCR)Nature Protocols, 2007
- Proximity among Distant Regulatory Elements at the β-Globin Locus Requires GATA-1 and FOG-1Molecular Cell, 2005
- DNA methylation represses transcription in vivoNature Genetics, 1999